Al Kildani | VP of IR and Business Development |
Russell Cox | CEO |
Mike Swanson | EVP & CFO |
Rob Ashley | EVP and Chief Technical Officer |
Jonathan Aschoff | National Securities |
Katherine Xu | William Blair |
Laura Chico | Raymond James |
Good day, ladies and gentlemen, and welcome to the Vital Therapies' Fourth Quarter 2017 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Mr.